AMD-070 Hydrochloride: Applied Workflows for CXCR4 Antagonis
2026-05-12
AMD-070 hydrochloride (Mavorixafor hydrochloride) empowers researchers to precisely modulate the CXCR4/CXCL12 axis in both rare immunodeficiencies and anti-HIV research. Its high solubility, oral bioavailability, and robust safety profile set it apart for advanced translational and mechanistic studies.
Pentoxifylline as a Phosphodiesterase Inhibitor in Inflammat
2026-05-11
Pentoxifylline stands out as a versatile phosphodiesterase inhibitor, enabling robust in vitro and in vivo modeling of anti-inflammatory and immunomodulatory effects. Explore optimized workflows, troubleshooting strategies, and recent formulation innovations that maximize reproducibility and translational relevance.
Minoxidil sulphate: Applied Workflows in Vascular & Hair Gro
2026-05-11
Minoxidil sulphate, the active metabolite of minoxidil, is revolutionizing precision in both vascular biology and hair growth research. This article translates recent reference breakthroughs and APExBIO’s validated specifications into actionable protocols, troubleshooting advice, and comparative insights for laboratory scientists.
ZCL278: Precision Cdc42 Inhibition for Pathway Dissection an
2026-05-10
Explore how ZCL278, a selective Cdc42 inhibitor, enables rigorous, mechanistic research into cell motility suppression and neuronal branching inhibition. This article provides a uniquely practical, assay-centric perspective and critical insights from recent breakthroughs.
Belinostat (PXD101): Strategic Advances in Epigenetic Cancer
2026-05-09
This thought-leadership article explores the mechanistic underpinnings and translational guidance for employing Belinostat (PXD101) in cancer research. Drawing on foundational in vitro drug response frameworks and recent comparative literature, it empowers researchers to harness precision histone deacetylase inhibition for bladder and prostate cancer models. The discussion advances beyond standard product narratives, spotlighting APExBIO’s Belinostat as a pivotal tool for robust, reproducible epigenetic studies and translational innovation.
Recombinant Mouse Sonic Hedgehog: Optimizing Patterning Assa
2026-05-09
Harness Recombinant Mouse SHH for reproducible limb, brain, and urogenital developmental studies—now with actionable protocol insights and troubleshooting guidance. Discover how precise morphogen delivery, validated by recent comparative research, empowers breakthrough experiments in congenital malformation research and hedgehog signaling pathway dissection.
Targeting SCUBE3: A Novel Strategy to Suppress Cancer Progre
2026-05-08
This study identifies the secretory protein SCUBE3 as a critical driver of cancer cell survival, therapy resistance, and immune evasion. Through engineering a first-in-class neutralizing antibody that targets SCUBE3, the researchers demonstrate a significant reduction in tumor growth and metastasis, providing a promising direction for pan-cancer therapy.
CBD Modulates Orofacial Pain via Cannabinoid and Serotonin P
2026-05-07
This study reveals that cannabidiol (CBD) robustly alleviates both the sensory and emotional dimensions of orofacial inflammatory pain in mice. Through rigorous behavioral and molecular analyses, the authors demonstrate that CBD orchestrates peripheral and central mechanisms, with important implications for translational pain management and neuropharmacology.
Amt-1: Dual Antiviral and Immunomodulatory Actions Against I
2026-05-07
This study introduces Amt-1, an amantadine derivative with potent efficacy against influenza A virus (IAV), including drug-resistant strains. By activating the Nrf2/HO-1 pathway and inhibiting NF-κB, Amt-1 demonstrates a unique host-directed mechanism that reduces inflammation and viral replication, offering a novel therapeutic avenue for resistant IAV infections.
Cholesterol Impedes Lipid Nanoparticle Trafficking in Cells
2026-05-06
This study reveals that increased cholesterol content in lipid nanoparticles (LNPs) leads to the aggregation of LNP-endosomes at the cell periphery, hindering intracellular trafficking and reducing nucleic acid delivery efficiency. The findings have direct implications for optimizing LNP formulations in RNA therapeutics and highlight the need for precise control of lipid ratios in delivery systems.
BLISTER Regulates HYL1 Phosphorylation and miRNA Biogenesis
2026-05-06
This study uncovers how the plant-specific protein BLISTER (BLI) coordinates transcriptional and post-translational mechanisms to control miRNA biogenesis in Arabidopsis, particularly through regulation of HYL1 phosphorylation and nuclear import. These findings highlight novel regulatory nodes in plant gene expression and provide a framework for dissecting phosphorylation-dependent signaling pathways.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Label Benchmark for mR
2026-05-05
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables direct, quantitative tracking of mRNA uptake and translation efficiency in live cells. Its Cap 1 structure with 5-methoxyuridine modification reduces innate immune activation and enhances intracellular stability. This product underpins robust, reproducible mRNA delivery assays for gene regulation studies.
Biochemical Characterization of GOB-38 β-Lactamase in E. ano
2026-05-05
This study provides a detailed biochemical and substrate specificity profile of the novel GOB-38 metallo-β-lactamase in Elizabethkingia anophelis, identifying its expansive antibiotic hydrolysis range and unique active site features. The findings highlight molecular mechanisms underlying multidrug resistance and raise concerns about transferable carbapenem resistance in clinical co-infection contexts.
BMS-777607: Advanced c-Met Inhibitor for Platelet and Cancer
2026-05-04
BMS-777607 stands out as a selective c-Met inhibitor powering both cancer metastasis and hiPSC-derived platelet bioproduction platforms. This article unpacks experimental workflows, troubleshooting strategies, and protocol refinements that maximize its translational impact in stem cell and oncology research.
25-Hydroxycholesterol Drives Immunosuppressive Macrophage Me
2026-05-04
Xiao et al. (2024) reveal a mechanism by which 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), activating AMPK and metabolic reprogramming that enhances immunosuppression. Their findings illuminate a metabolic checkpoint in the tumor microenvironment, suggesting new avenues for immunotherapy and cancer metabolism research.
459 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page